These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 18696022)
1. Clinical evaluation of a novel occluder device (Occlutech) for percutaneous transcatheter closure of patent foramen ovale (PFO). Krizanic F; Sievert H; Pfeiffer D; Konorza T; Ferrari M; Figulla HR Clin Res Cardiol; 2008 Dec; 97(12):872-7. PubMed ID: 18696022 [TBL] [Abstract][Full Text] [Related]
2. The Occlutech Figulla PFO and ASD occluder: a new nitinol wire mesh device for closure of atrial septal defects. Krizanic F; Sievert H; Pfeiffer D; Konorza T; Ferrari M; Hijazi Z; Jung C; Lauten A; Figulla HR J Invasive Cardiol; 2010 Apr; 22(4):182-7. PubMed ID: 20351390 [TBL] [Abstract][Full Text] [Related]
3. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device. Fischer D; Haentjes J; Klein G; Schieffer B; Drexler H; Meyer GP; Schaefer A J Interv Cardiol; 2011 Feb; 24(1):85-91. PubMed ID: 20735710 [TBL] [Abstract][Full Text] [Related]
4. Amplatzer or Figulla Flex II Occluder: a comparative study of outcomes after transcatheter patent foramen ovale closure. Toggweiler S; Moccetti F; Conrad N; Loretz L; Madanchi M; Bossard M; Attiger-Toller A; Cuculi F; Wolfrum M J Invasive Cardiol; 2024 Apr; 36(4):. PubMed ID: 38412438 [TBL] [Abstract][Full Text] [Related]
5. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale. Aral M; Mullen M Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379 [TBL] [Abstract][Full Text] [Related]
6. Transcatheter closure of patent foramen ovale with the Spider patent foramen ovale occluder: a prospective, single-center trial. Zhang CJ; Huang YG; Huang XS; Huang T; Huang WH; Shen JJ; Xun ZR Chin Med J (Engl); 2010 Apr; 123(7):834-7. PubMed ID: 20497673 [TBL] [Abstract][Full Text] [Related]
7. Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale. Saguner AM; Wahl A; Praz F; de Marchi SF; Mattle HP; Cook S; Windecker S; Meier B Catheter Cardiovasc Interv; 2011 Apr; 77(5):709-14. PubMed ID: 20931665 [TBL] [Abstract][Full Text] [Related]
8. Echocardiographic findings in simple and complex patent foramen ovale before and after transcatheter closure. Vitarelli A; Mangieri E; Capotosto L; Tanzilli G; D'Angeli I; Toni D; Azzano A; Ricci S; Placanica A; Rinaldi E; Mukred K; Placanica G; Ashurov R Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1377-85. PubMed ID: 25139906 [TBL] [Abstract][Full Text] [Related]
9. Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results. Aytemir K; Oto A; Özkutlu S; Canpolat U; Kaya EB; Yorgun H; Şahiner L; Sunman H; Ateş AH; Kabakçı G Congenit Heart Dis; 2013; 8(5):418-27. PubMed ID: 23601507 [TBL] [Abstract][Full Text] [Related]
10. Implantation of a Occlutech Figulla PFO occluder in a patient with patent foramen ovale and history of embolic stroke. Krecki R; Peruga JZ; Plewka M; Krzemińska-Pakuła M; Kasprzak JD Cardiol J; 2008; 15(4):380-2. PubMed ID: 18698549 [TBL] [Abstract][Full Text] [Related]
12. Safety and performance of the Spider™ patent foramen ovale occluder. Edwards-Lehr T; Franke J; Bertog SC; Bäcker C; Wunderlich N; Hofmann I; Wilson N; Piechaud JF; Sievert H Catheter Cardiovasc Interv; 2013 Feb; 81(2):317-23. PubMed ID: 22887130 [TBL] [Abstract][Full Text] [Related]
13. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism. Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745 [TBL] [Abstract][Full Text] [Related]
14. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack. Steinberg DH; Bertog SC; Momberger J; Franke J; Hofmann I; Renkhoff K; Joy S; Vaskelyte L; Sievert H Catheter Cardiovasc Interv; 2015 Jun; 85(7):1262-7. PubMed ID: 24948394 [TBL] [Abstract][Full Text] [Related]
15. Transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Procedural and follow-up results after implantation of the Starflex occluder device with conjunctive intensified anticoagulation regimen. Fischer D; Fuchs M; Schaefer A; Schieffer B; Jategaonkar S; Hornig B; Drexler H; Meyer GP J Interv Cardiol; 2008 Apr; 21(2):183-9. PubMed ID: 18312307 [TBL] [Abstract][Full Text] [Related]
16. Transthoracic echocardiography guidance during percutaneous closure of patent foramen ovale. Oto A; Aytemir K; Ozkutlu S; Kaya EB; Yorgun H; Canpolat U; Ateş AH; Ozkutlu H Echocardiography; 2011 Nov; 28(10):1074-80. PubMed ID: 21967656 [TBL] [Abstract][Full Text] [Related]
17. Initial use of the new GORE(®) septal occluder in patent foramen ovale closure: implantation and preliminary results. MacDonald ST; Daniels MJ; Ormerod OJ Catheter Cardiovasc Interv; 2013 Mar; 81(4):660-5. PubMed ID: 23436483 [TBL] [Abstract][Full Text] [Related]
18. [Transcatheter closure of atrial septal defects in adults. Practicality and safety of four different closure systems used in 102 patients]. La Rosée K; Krause D; Becker M; Beuckelmann DJ; Deutsch HJ; Höpp HW Dtsch Med Wochenschr; 2001 Sep; 126(38):1030-6. PubMed ID: 11565056 [TBL] [Abstract][Full Text] [Related]
19. Amplatzer left atrial appendage occlusion through a patent foramen ovale. Koermendy D; Nietlispach F; Shakir S; Gloekler S; Wenaweser P; Windecker S; Khattab AA; Meier B Catheter Cardiovasc Interv; 2014 Dec; 84(7):1190-6. PubMed ID: 24399612 [TBL] [Abstract][Full Text] [Related]